“Clarity and the rally are the same event” (NOTW#105)
Moderna and Merck reported positive Phase III INTerpath-001 results for a personalized cancer vaccine, turning clinical clarity into a…
Saturday, August 22
Everything we published on this day.
29 stories — the front page that day →
Moderna and Merck reported positive Phase III INTerpath-001 results for a personalized cancer vaccine, turning clinical clarity into a…
Churchill Downs is selling regional casinos to focus on horse racing and historical racing machines, where Exacta software and racetrack…
CAAP reported decent second-quarter earnings and its first dividend, while Brazil rose on an election poll and USMCA trade developments…
Eton Pharmaceuticals licensed rare-disease medicines, raised revenue guidance twice and climbed more than fourfold from its February 2026…
@PythiaR @BillBrewsterTBB You know it’s Joe Burnett! $MAMA ceo Adam Michaels is impressive
@scottfelsenthal It used to be on my do not buy list. However, it’s back on my watchlist. For the record, $SIF was also on my do not buy list for years. 🤐… until recently.. Regarding $OML.V, I think they’ve been setting that gross margin expansion target for a while. So, we’ll have to see.
👀 Potential $SIF InfoArb worth digging into… $RTX (Raytheon) just received a massive $22.9B, 7-year Tomahawk contract, with production targeted to ramp to 1,000+ missiles/year. What’s interesting is that Raytheon says the production ramp will “require investment across its supply chain and working with hundreds of small and midsized suppliers.” $SIF explicitly says its military-aerospace forgings are used in “Missile & Ordnance” applications. They also list Raytheon among its customers Given that Raytheon is now “looking across its supplier base to support an enormous munitions ramp,” does SIF maybe have a fighting chance here? There are probably more direct beneficiaries than SIF. But for its size, even a relatively small piece of the work could move the needle… it’s a rabbit hole worth digging into. 🔎… Time for @realLigerCub to step in :) Important caveat: I have found no evidence that SIF supplies Tomahawk, or even that its existing Raytheon relationship is tied specifically to Raytheon’s missile business.
@UnderlyingValue Yeah, they've mostly come through with what they said they would do over the years. They're also non-promotional. The operating leverage in the model is substantial. A comp just went bankrupt. Some good stuff here. Thanks to @OlivierColombo for pitching $LEAT to me in 2019.
Lots of information arbitrage homework to do this weekend… $LEAT is probably my favorite set up right now from the latest batch of Delta Sheets.. Also closely watching $PRPO sales/scale expansion strategy. https://t.co/jsup7PKOb7
Teleflex is divesting lower-growth units, using proceeds for debt reduction and buybacks while focusing on faster-growing Vascular and…
Niu Technologies’ Q2 FY2026 earnings worsened despite putting the electric scooter maker on track for record annual results; revenue growth…
Triple Flag Precious Metals' Ravenswood acquisition adds long-term, low-cost gold stream revenue, diversifies cash flows and extends growth…
@Ross__Hendricks @DratchCap @WarrenPies Equity is abundant even while absolute debt issuance skyrockets. I would think prudent capital allocators would tap the former… (see $GOOG, $ORCL as of late)
Jensen is clearly very smart, and I think he was wise to seed the neocloud industry ($NVDA customers) to help offset the dominance of the hyperscalers (ASIC customers). But that doesn’t change the competitive reality that he has to use $NVDA’s balance sheet to buy business… (and his customers are doing the same with their balance sheets)
Energy Fuels produces uranium and separated rare earth elements at its White Mesa Mill, with NdPr output since April 2024 and a domestic…
@davey_juice @taobanker I own both. $NU seems inevitable. $INTR more execution and single-market risk but a lot more upside if it works and gets rerated.
Eli Lilly holds 60–61% of the US obesity-drug market as prescriptions and international expansion offset pricing pressure from Novo Nordisk.
Instacart’s larger grocery baskets create disproportionately better delivery economics than DoorDash’s, making half the basket size worth…
Nvidia’s exclusive SpaceX partnership targets a 10 GW data-center buildout and could add $120 billion to $230 billion of revenue beyond…
@taobanker $INTR at 1.2x book 5.5x '27 earnings with a 16% ROE growing at 20% a year probably qualifies. But yes, $BLX is incredible and I still kick myself for selling most of my position at $25 after buying at $15. Grabbed defeat from the jaws of victory there.
TG Therapeutics' Briumvi growth and subcutaneous formulation progress have fueled takeover rumors, with Biogen, Incyte and Sanofi cited as…
DICK’S Sporting Goods trades at 12.8 times FY26 EPS after breaking multi-year support, while maintaining $13.50 to $14.50 FY guidance amid…
OPENLANE trades near $34 after Apax Partners’ exit, with a $25 million buyback and FY2026 adjusted EBITDA guidance raised to $385–$400…
Applied Materials targets AI-driven foundry, DRAM and advanced-packaging demand, expected to drive 80% of wafer-fab equipment growth…
NextDecade’s Rio Grande LNG ownership rises from 20.8% in Phase 1 to 60% in Train 4 and 70% in Train 5, increasing cash flow exposure as…
Seagate’s FY2026 margin expansion reflects favorable HDD pricing, mix and industry supply discipline, raising the risk that cyclical…
Centene’s Medicaid margins are recovering ahead of schedule, Medicare is nearing profitability, and Marketplace risk adjustment is…
Realty Income raised AFFO guidance to $4.44 to $4.45 and targets $10 billion of 2026 investments, with European expansion supporting its…
General Dynamics’ Q2 beat, 1.5 book-to-bill ratio and $136.5 billion backlog support an upgrade, with Aerospace margin gains and Marine…